Zobrazeno 1 - 5
of 5
pro vyhledávání: '"A S Panevina"'
Publikováno v:
Терапевтический архив, Vol 90, Iss 10, Pp 79-83 (2018)
Aim. To determine the effects of menopausal hormone therapy dosage on levels of proinflammatory cytokines and immunoglobulins in bodily fluids of patients with type 2 diabetes mellitus (DM) and chronic obstructive pulmonary disease (COPD) during peri
Externí odkaz:
https://doaj.org/article/a859db440f54457ebd0783bb09b3e778
Autor:
E. A. Shestakova, I. A. Sklyanik, A. S. Panevina, A. V. Yurasov, Yu. I. Yashkov, M. S. Sineokaya, A. O. Gavrilova, V. V. Evdoshenko, V. V. Fedenko, N. S. Bordan, M. V. Shestakova
Publikováno v:
Сахарный диабет, Vol 26, Iss 5, Pp 446-454 (2023)
There are several models for predicting remission of type 2 diabetes mellitus (T2D) a year after bariatric surgery — DiaRem, ABSD, IMS, etc. However, these models cannot be used to predict the early normalization of glycemia (within a few months af
Externí odkaz:
https://doaj.org/article/3cd1928399ec497bb4297338bc492b2a
Autor:
E. A. Shestakova, I. A. Sklyanik, A. S. Panevina, L. V. Nikankina, M. V. Shestakova, I. I. Dedov
Publikováno v:
Терапевтический архив, Vol 92, Iss 10, Pp 15-22 (2020)
Aim.Obese patients without diabetes present an interesting phenotype to explore protective mechanisms against type 2 diabetes (T2D) development. In our study we looked for specific hormonal features of obese patients without T2D. Materials and met
Externí odkaz:
https://doaj.org/article/e542d61f981246518d605deeea6397c7
Autor:
Ivan Ivanovich Dedov, A S Panevina, Marina Vladimirovna Shestakova, Igor A. Sklyanik, Ekaterina A. Shestakova, Larisa Nikankina
Publikováno v:
Терапевтический архив, Vol 92, Iss 10, Pp 15-22 (2020)
Obese patients without diabetes present an interesting phenotype to explore protective mechanisms against type 2 diabetes (T2D) development. In our study we looked for specific hormonal features of obese patients without T2D.We included 6 groups of p
Publikováno v:
Terapevticheskii arkhiv. 90(10)
To determine the effects of menopausal hormone therapy dosage on levels of proinflammatory cytokines and immunoglobulins in bodily fluids of patients with type 2 diabetes mellitus (DM) and chronic obstructive pulmonary disease (COPD) during perimenop